Exoskeleton Assistance for Post-Stroke Gait Improvement
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests robotic exoskeleton devices designed to help stroke survivors walk better. Participants will use two types of exoskeletons: one for the hip (Hip Exoskeleton) and one for the ankle (Ankle Exoskeleton), to determine which improves walking in real-world settings. The trial focuses on finding a personalized fit that aids movement without hindering it. It may suit individuals who had a stroke at least six months ago, can walk independently without a walker, and live on their own. As an unphased trial, this study offers a unique opportunity to explore innovative technology that could enhance mobility and independence.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exoskeleton device is safe for post-stroke gait improvement?
Research has shown that exoskeleton devices for the ankle and hip can improve walking after a stroke. Studies have found that ankle exoskeletons assist with hemiplegic gait, a common walking difficulty post-stroke. These devices are generally easy to use and often enhance joint movement and balance.
For hip exoskeletons, research suggests they can increase walking speed, endurance, and balance. They are usually safe and effective for stroke recovery, and users often notice improved walking abilities after training with these devices.
Both ankle and hip exoskeletons prioritize safety, and current findings support their use in rehabilitation.12345Why are researchers excited about this trial?
Researchers are excited about exoskeleton assistance for stroke survivors because it offers a novel way to improve walking ability. Unlike traditional rehabilitation therapies that rely on physical exercises and manual assistance, exoskeletons provide mechanical support directly to the joints, specifically the ankle and hip. This technology can enhance mobility by allowing more natural and efficient movements, potentially reducing the energy expenditure required for walking. By integrating advanced mechanics with rehabilitation, exoskeletons might offer faster and more measurable improvements in gait for stroke survivors.
What evidence suggests that these exoskeleton devices are effective for improving post-stroke gait?
This trial will compare the effectiveness of two types of exoskeletons for post-stroke gait improvement: the Ankle Exoskeleton and the Hip Exoskeleton. Research has shown that wearable ankle robots can help stroke survivors walk better, proving more effective than regular walking exercises in increasing speed and stability. Studies have found that these devices can adjust the assistance they provide based on the user's gait, making them highly adaptable.
For hip exoskeletons, research indicates they can enhance walking speed and stamina in stroke survivors. Users of these devices have demonstrated improvements in balance and overall movement. Both ankle and hip exoskeletons offer powered support, making walking easier and more effective for stroke survivors. Participants in this trial will use both types of exoskeletons in separate sessions to assess their effectiveness.13467Who Is on the Research Team?
Aaron Young, PhD
Principal Investigator
Georgia Institute of Technology
Greg Sawicki
Principal Investigator
Georgia Institute of Technology
Are You a Good Fit for This Trial?
This trial is for chronic stroke survivors aged 18-85 who can walk at least a little bit and have been living with the condition for over six months. They should be able to sit without help, transfer from sitting to standing, handle small slopes and steps, and commit to a few hours of testing with breaks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Acclimation and Testing
Participants acclimate to the exoskeleton device and undergo various walking tests both indoors and outdoors, including a 10 meter walk test and a 6-minute walk test.
Follow-up
Participants are monitored for safety and effectiveness after testing, including assessments of perceived exertion and physiological cost index.
What Are the Treatments Tested in This Trial?
Interventions
- Ankle Exoskeleton
- Hip Exoskeleton
Ankle Exoskeleton is already approved in United States for the following indications:
- Mobility assistance for individuals with cerebral palsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia Institute of Technology
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator